Back to all articles

As global benchmark interest rates remain elevated and geopolitical uncertainty continues to reshape capital markets, ultra-high-net-worth individuals and family offices are rethinking how they access liquidity. The answer, increasingly, is non-recourse, asset-backed financing.

What is Non-Recourse Financing?

In a traditional loan, the lender has full recourse to the borrower's personal and corporate assets if the borrower defaults. Non-recourse financing flips this model: the lender's only remedy in a default is the pledged collateral itself. The borrower faces no personal liability, no joint liability, and no impact on their credit record.

"The borrower retains their position, their privacy, and their long-term strategy — while accessing the capital they need today."

Why It's Gaining Traction

Several converging forces are driving demand for non-recourse structures:

Who Benefits Most?

Non-recourse financing is particularly powerful for shareholders of listed companies who hold significant equity positions but cannot sell without moving the market or triggering insider-trading restrictions. It is equally compelling for family offices managing multigenerational wealth who need liquidity without disturbing underlying investment strategies.

The Medcorp Approach

At Medcorp, every financing structure is non-recourse by default. We work with licensed securities lenders and institutional custodians to ensure your assets are protected, non-rehypothecated (on long-term products), and returned in full upon settlement. Our process is designed to be fast, confidential, and frictionless — from first inquiry to funded in as little as one week.

If you hold listed equities, digital assets, or ETF positions and want to explore what liquidity is available to you, reach out to our team for a confidential consultation.

Ready to explore your financing options?

Our team responds within 1–2 working days — completely confidential.

Request Funding →